However, increased circulating alpha fetoprotein (AFP), the most commonly used circulating biomarker for HCC, has been observed in patients without HCC, such as those with chronic hepatitis B or C, suggesting the poor specificity of AFP for HCC [3, 6]. Here, AFP is linked to hepatocellular carcinoma.